The use of sacubitril / valsartan in Takotsubo syndrome with severe impairment of left ventricular systolic function
Pol Arch Intern Med
.
2023 Sep 29;133(9):16545.
doi: 10.20452/pamw.16545.
Epub 2023 Aug 9.
Authors
Małgorzata Zalewska-Adamiec
1
,
Hanna Bachórzewska-Gajewska
2
,
Sławomir Dobrzycki
2
Affiliations
1
Department of Invasive Cardiology, Medical University of Bialystok, Białystok, Poland. mzalewska5@wp.pl
2
Department of Invasive Cardiology, Medical University of Bialystok, Białystok, Poland
PMID:
37555507
DOI:
10.20452/pamw.16545
No abstract available
MeSH terms
Heart Failure*
Humans
Takotsubo Cardiomyopathy*
Treatment Outcome
Valsartan
Ventricular Function, Left
Substances
sacubitril
Valsartan